FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/09/027900 [Registered on: 18/09/2020] Trial Registered Prospectively
Last Modified On: 17/09/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Siddha 
Study Design  Single Arm Study 
Public Title of Study   A CLINICAL TRIAL TO STUDY THE EFFECT OF SIDDHA DRUG PAVALA VEERA CHUNNAM IN PATIENTS HAVING CHOLELITHIASIS 
Scientific Title of Study   PHASE II NON-RANDOMIZED OPEN CLINICAL EVALUATION OF SIDDHA MEDICINE PAVALA VEERA CHUNNAM FOR SATHTHI PITHAM (CHOLELITHIASIS) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Nikil Niva J 
Designation  pg scholar 
Affiliation  Government Siddha Medical College Chennai 
Address  Department of General Medicine Government Siddha Medical College 6 Anna Arch road Nsk Nagar arumbakkam Chennai Tamilnadu 600106

Chennai
TAMIL NADU
600106
India 
Phone  7200333774  
Fax    
Email  nikilniva@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sasirekha R 
Designation  Lecturer 
Affiliation  Government Siddha Medical College Chennai 
Address  Department of General Medicine Government Siddha Medical College 6 Anna Arch road Nsk Nagar arumbakkam Chennai Tamilnadu 600106

Chennai
TAMIL NADU
600106
India 
Phone  9444832728  
Fax    
Email  sasirekha.siddha@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Nikil Niva j 
Designation  pg scholar 
Affiliation  Government Siddha Medical College Chennai 
Address  Department of General Medicine Government Siddha Medical College 6 Anna Arch road Nsk Nagar arumbakkam Chennai Tamilnadu 600106

Chennai
TAMIL NADU
600106
India 
Phone  7200333774  
Fax    
Email  nikilniva@gmail.com  
 
Source of Monetary or Material Support  
Government Siddha Medical College 6 Anna Arch road Nsk Nagar arumbakkam Chennai Tamilnadu 600106 
 
Primary Sponsor  
Name  Government Siddha Medical College Chennai 
Address  Government Siddha Medical College 6 Anna Arch road Nsk Nagar arumbakkam Chennai Tamilnadu 600106 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
nil   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nikil Niva J  Arignar Anna Government Hospital for Indian Medicine  Room No 2 Siddha Department Department of General Medicine 6 Anna Arch road Nsk Nagar arumbakkam Chennai Tamilnadu 600106
Chennai
TAMIL NADU 
07200333774

nikilniva@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K808||Other cholelithiasis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  nil  nil 
Intervention  Pavalaveera Chunnam   65mg of Pavalaveera Chunnam is Administrated twice a day with milk for 48 days 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Accidentally identified gall stone in USG
Asymptomatic Cholelithiasis.
Stone Size less than 8mm (normal lumen size is 8mm)
 
 
ExclusionCriteria 
Details  Pregnant and lactating mothers.
Cholecystitis.
Pancreatitis
Obstructive Jaundice.
Choledo Cholelithiasis
Acute Cholelithiasis
Gall Stone patients with other comorbidities
Malignancy of gall bladder
-Will be excluded clinically or based on available medical reports
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Outcome is mainly assessed by reduction in clinical symptoms measured by reduction in size of gall stones with interpretation of USG abdomen.  48days. 
 
Secondary Outcome  
Outcome  TimePoints 
nil  nil 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   21/09/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not Yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is Phase II Non -Randomized open Clinical Trial to study the safety and efficacy of siddha drug PAVALAVEERA CHUNNAM. The drug is given 65mg twice a day for 48 days. clinical trial is conducted after conducting preclinical studies. The Siddha Drug is mentioned in THE PHARMACOPOEIA OF SIDDHA RESEARCH MEDICINES . During the trial all the study related data will be recorded and documented. After the completion of trial all the data will be analyzed statistically. 
Close